SCHEMBL8736013

SCHEMBL8736013

CC(=O)Oc1ccc(C(C)NS(=O)(=O)c2ccc3ccc(OCc4ccc5ccccc5n4)cc3c2)cc1C

nearest known ligand 0.64

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYSLTR1 Q9Y271 8/20 0.64
ADAMTS4 O75173 1/20 0.51
ALOX5 P09917 1/20 0.49
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
PDE3B Q13370 1/20 0.49
PDE3A Q14432 1/20 0.49
CYSLTR2 Q9NS75 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8735750 0.88 CYSLTR1 (0.69) CYSLTR1ADAMTS4ALOX5PDE4APDE4B
SCHEMBL8735747 0.88 CYSLTR1 (0.65) CYSLTR1ADAMTS4CYSLTR2
SCHEMBL8736503 0.83 CYSLTR1 (0.77) CYSLTR1ADAMTS4ALOX5PDE4APDE4B
SCHEMBL8735635 0.82 CYSLTR1 (0.68) CYSLTR1ADAMTS4ALOX5PDE4APDE4B
SCHEMBL8735894 0.78 CYSLTR1 (1.00) CYSLTR1ADAMTS4ALOX5PDE4APDE4B
SCHEMBL8732424 0.77 CYSLTR1 (0.86) CYSLTR1ADAMTS4ALOX5PDE4APDE4B
SCHEMBL8734137 0.76 CYSLTR1 (0.63) CYSLTR1ADAMTS4ALOX5PDE4APDE4B
SCHEMBL8736469 0.76 CYSLTR1 (0.72) CYSLTR1ALOX5PDE4APDE4BPDE4C
SCHEMBL8736033 0.75 CYSLTR1 (0.85) CYSLTR1ADAMTS4CYSLTR2
SCHEMBL8734127 0.75 CYSLTR1 (1.00) CYSLTR1ADAMTS4CYSLTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0874826-A1 NAPHTHALENE QUINOLINES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION LABORATORIOS MENARINI S.A. (ES) 1998-11-04 EP disclosed
WO-1997024331-A1 NAPHTHALENE QUINOLINES HAVING LEUKOTRIENE-ANTAGONISTIC ACTION LABORATORIOS MENARINI S.A. (ES) 1997-07-10 WO disclosed